# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-24-000028
Filing Date
2024-08-08
Accepted
2024-08-08 07:12:14
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | howl-20240630.htm iXBRL | 10-Q | 1469200
2 | EX-4.1 | a6302024ex41.htm | EX-4.1 | 69036
3 | EX-10.1 | a06302024ex101.htm | EX-10.1 | 397147
4 | EX-31.1 | a06302024ex311.htm | EX-31.1 | 10336
5 | EX-31.2 | a06302024ex312.htm | EX-31.2 | 10360
6 | EX-32.1 | a06302024ex321.htm | EX-32.1 | 7039
| Complete submission text file | 0001785530-24-000028.txt |  | 6440336

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | howl-20240630.xsd | EX-101.SCH | 37753
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | howl-20240630_cal.xml | EX-101.CAL | 52673
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | howl-20240630_def.xml | EX-101.DEF | 194933
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | howl-20240630_lab.xml | EX-101.LAB | 459648
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | howl-20240630_pre.xml | EX-101.PRE | 346773
69 | EXTRACTED XBRL INSTANCE DOCUMENT | howl-20240630_htm.xml | XML | 637723

Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 241186013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)